VTGN
Vistagen Therapeutics, Inc.- Last price
- $0.58
- As of
Active signals for VTGN
- mediumEARNINGS_BEAT
Beat consensus by 14.7% — EPS $-0.432 vs $-0.5066 estimate
- mediumEARNINGS_BEAT
Beat consensus by 9.2% — EPS $-0.45 vs $-0.4957 estimate
- mediumEARNINGS_MISS
Missed consensus by 11.2% — EPS $-0.54 vs $-0.4855 estimate
- mediumEARNINGS_BEAT
Beat consensus by 9.2% — EPS $-0.45 vs $-0.4957 estimate
- mediumEARNINGS_BEAT
Beat consensus by 14.7% — EPS $-0.432 vs $-0.5066 estimate
Top institutional holders of VTGN (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $1.5M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $1M | 0.00% | , |
| CITADEL ADVISORS LLC | $353K | 0.00% | , |
| CITADEL ADVISORS LLC | $308K | 0.00% | +367.4% |
| TWO SIGMA INVESTMENTS, LP | $268K | 0.00% | +140.1% |
| RENAISSANCE TECHNOLOGIES LLC | $166K | 0.00% | +81.2% |
| MILLENNIUM MANAGEMENT LLC | $130K | 0.00% | +853.0% |
| TWO SIGMA INVESTMENTS, LP | $129K | 0.00% | -32.4% |
| MILLENNIUM MANAGEMENT LLC | $122K | 0.00% | +8.6% |
| RENAISSANCE TECHNOLOGIES LLC | $106K | 0.00% | -61.9% |
| MILLENNIUM MANAGEMENT LLC | $73K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, VTGN
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
See more VTGN signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track VTGN in your watchlist and get notified the moment a new signal fires.
Track VTGN on Kresmion →